BRCA1 and ovarian carcinoma: The aim of the present study was to investigate the contribution of PALB2 germline mutations in a group of 460 BRCA1/2-mutation negative breast and/or ovarian cancer patients and identify the optimal panel of recurrent mutations for genetic screening of PALB2.